Related Experiment Video
Updated: Nov 4, 2025

07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
11.9K
Cardiovascular adverse events in pregnancy: A global perspective
1Aswan Heart Centre, Aswan, Egypt.
Global Cardiology Science & Practice
|May 26, 2021
Summary
Pregnant women with heart disease face serious cardiovascular risks during and after pregnancy. Early awareness and management strategies, including specialized clinics, can prevent many maternal deaths from these events.
Area of Science:
- Cardiology
- Obstetrics
- Maternal Health
Background:
- Cardiovascular adverse events (AE) are a major cause of maternal mortality and morbidity globally.
- These events can be directly caused by pregnancy or related to pre-existing conditions, posing risks throughout pregnancy and postpartum.
- There is a growing understanding of the long-term link between pregnancy-related cardiovascular issues and future cardiovascular disease (CVD).
Purpose of the Study:
- To discuss the global distribution of cardiovascular maternal mortality.
- To review adverse cardiovascular events during and after pregnancy, including their predictors and risk stratification.
- To explore preventative solutions, highlighting the role of cardio-obstetric clinics.
Main Methods:
- Review of global data on cardiovascular maternal mortality.
- Analysis of adverse events, their causes (direct/indirect), and risk factors.
- Discussion of preventative strategies and management models like cardio-obstetric clinics.
Main Results:
- Cardiovascular adverse events represent a significant and often preventable cause of maternal mortality worldwide.
- Risk stratification and early identification of predictors are crucial for managing these events.
- Cardio-obstetric clinics show promise as a solution for improving care and outcomes.
Conclusions:
- Increasing awareness of cardiovascular risks in pregnancy is vital for prevention.
- Implementing targeted prevention and treatment strategies can reduce maternal mortality.
- Specialized cardio-obstetric services are essential for managing pregnant women with heart disease and mitigating risks.
More Related Videos
Related Concept Videos
Teratogenicity
3.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.4K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
848
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
848
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.6K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K
Diabetes Mellitus: Type 2 and Gestational
3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pathophysiology of Diabetes
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Pharmacovigilance
1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K

